Skip to content
Engineering, Medical Health Aged Care

New research shows AI can ask another AI for a second opinion on medical scans

Monash University 2 mins read

Researchers at Monash University have designed a new co-training AI algorithm for medical imaging that can effectively mimic the process of seeking a second opinion. 

Published recently in Nature Machine Intelligence, the research addressed the limited availability of human annotated, or labelled, medical images by using an adversarial, or competitive, learning approach against unlabelled data.

This research, by Monash University faculties of Engineering and IT, will advance the field of medical image analysis for radiologists and other health experts.

PhD candidate Himashi Peiris of the Faculty of Engineering, said the research design had set out to create a competition between the two components of a "dual-view" AI system. 

One part of the AI system tries to mimic how radiologists read medical images by labelling them, while the other part of the system judges the quality of the AI-generated labelled scans by benchmarking them against the limited labelled scans provided by radiologists,” said Ms Peiris.

“Traditionally radiologists and other medical experts annotate, or label, medical scans by hand highlighting specific areas of interest, such as tumours or other lesions. These labels provide guidance or supervision for training AI models.

“This method relies on the subjective interpretation of individuals, is time-consuming and prone to errors and extended waiting periods for patients seeking treatments.”

 

The availability of large-scale annotated medical image datasets is often limited, as it requires significant effort, time and expertise to annotate many images manually.

The algorithm developed by the Monash researchers allows multiple AI models to leverage the unique advantages of labelled and unlabelled data, and learn from each other's predictions to help improve overall accuracy.

“Across the three publicly accessible medical datasets, utilising a 10 per cent labelled data setting, we achieved an average improvement of 3 per cent compared to the most recent state-of-the-art approach under identical conditions,” said Ms Peiris.

“Our algorithm has produced groundbreaking results in semi-supervised learning, surpassing previous state-of-the-art methods. It demonstrates remarkable performance even with limited annotations, unlike algorithms that rely on large volumes of annotated data.

“This enables AI models to make more informed decisions, validate their initial assessments, and uncover more accurate diagnoses and treatment decisions.” 

The next phase of the research will focus on expanding the application to work with different types of medical images and developing a dedicated end-to-end product that radiologists can use in their practices.


About the paper

The study published in Nature Machine Intelligence was led by A/Professor Mehrtash Harandi and conducted by principal researcher, Himashi Peiris, a Ph.D. candidate at Monash University’s Faculty of Engineering, together with A/Professor Zhaolin Chen, Dr Munawar Hayat and Professor Gary Egan, from Monash Biomedical Imaging and the Faculty of Information Technology.  

-ends

For media enquiries please contact:

Loretta Wylde

Monash University

Media and Communications

E: [email protected]

T: +61 (0) 432 123 106

For more Monash media stories, visit our news and events site

For general media enquiries please contact:

Monash Media

E: [email protected]

T: +61 (0) 3 9903 4840

 

More from this category

  • Medical Health Aged Care, Women
  • 19/12/2025
  • 16:00
Breast Cancer Network Australia

Affordable access to life extending drug for people with incurable breast cancer.

Key Facts: Tucatinib, a breast cancer drug, will be listed on PBS, saving patients over $4,500 per month The drug is specifically for HER2-positive metastatic breast cancer patients, particularly those with brain metastases Interviews: Larissa King - woman living with breast cancer that has spread to the brain Vicki Durston. BCNA Director Policy, Advocacy and Support Services. People with breast cancer that has spread to the brain will save more than $4500 a month when Tucatinib is listed on the Pharmaceutical Benefits Scheme in the coming weeks. Breast Cancer Network Australia (BCNA) welcomes today’s decision by the Pharmaceutical Benefits Advisory…

  • Medical Health Aged Care
  • 19/12/2025
  • 09:05
Royal Australian College of GPs

RACGP celebrates WA excellence in general practice at awards

The Royal Australian College of General Practitioners (RACGP) WA Faculty has honoured outstanding contributions to general practice at its annual awards ceremony, celebrating leaders, educators, registrars, and practices across the state. The evening provided the opportunity to celebrate the College’s highest honour, the Rose-Hunt Award, awarded during GP25, which was presented to WA GP, Adjunct Associate Professor Frank R Jones, recognising his 45 years of service to general practice, including 40 years at Murray Medical Centre in Mandurah. Professor Jones has worked across rural, procedural, and community settings and held numerous leadership roles within the RACGP, including President, Vice President,…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.